Image

Development of utrophin modulators for the treatment of Duchenne Muscular Dystrophy

Image

Developing small molecules for the treatment of age-related diseases

Image

New agents for tumour detection and therapy

Image

Development of anti-inflammatory agents

Welcome to the Russell Group webpages. The Russell Group is based in the Department of Chemistry and the Department of Pharmacology at the University of Oxford. Explore our website to learn more about our group, collaborative research programmes and publications.


Latest news
Stacks Image 306
New publication in Angewandte Chemie
Research from the Russell group reveals the Arylhydrocarbon Receptor as the molecular target of the utrophin modulator ezutromid. Read more…
Stacks Image 309
Oxford Times/Mail profile: Angela Russell
Read the article in the Oxford Times profiling Angela Russell - how she began her career in medicinal chemistry and the ground-breaking regenerative medicine approach that OxStem is currently leading. Read more….
Stacks Image 283
Poster prize for Rachel
Well done to Rachel Sim for winning a prize for her poster at the MSD for the UK sponsored symposium on 24th October.
Publication highlights
Probing the function of inflammatory disease targets
Our new study in ACS Chemical Biology in collaboration with David Greaves' lab (Sir William Dunn School of Pathology) reveals how biased signalling at the GPR84 receptor can result in differing regulation of immune cell chemotaxis.
Image